Related Experiment Video
Updated: Feb 28, 2026
07:50
Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
7.0K
Approach to management of giant basal cell carcinomas
Sarah E Mott1, William J Hunter2, Edibaldo Silva3
1Division of Dermatology, Creighton University School of Medicine, Omaha, Nebraska, USA.
Cutis
|June 21, 2017
Summary
Basal cell carcinoma (BCC), a common skin cancer, can grow large and destructive. Complete surgical excision proved effective for a giant BCC case, with no recurrence in 36 months.
Area of Science:
- Dermatology
- Oncology
- Surgical Pathology
Background:
- Basal cell carcinoma (BCC) is a prevalent nonmelanoma skin cancer with rising global incidence.
- UV radiation exposure is a primary risk factor for BCC development.
- BCC malignancy is characterized by local invasion rather than metastasis, generally leading to a favorable prognosis.
Observation:
- A case report details a 60-year-old male with a large, locally destructive giant BCC on his upper back.
- The giant BCC was successfully treated with complete surgical excision (SE).
Findings:
- The patient experienced no recurrence of the giant BCC in the 36 months following surgical excision.
- This case highlights the efficacy of SE for large, locally invasive BCCs.
Implications:
- Surgical excision is a viable and effective treatment for giant basal cell carcinoma.
- Further review of surgical and nonsurgical modalities for giant BCC management is warranted.
